Healthcare
Syngene International Limited (SYNGENE)
Syngene International Limited (SYNGENE) is an NSE-listed Healthcare company. latest close ₹407.25, 1-day return +3.0%, 1-week return +1.4%. This page shows price, returns, and technical signals from QUANTSCASE. Informational only — not investment advice.
Data as of 20 Aug 2026
For informational and educational purposes only. Not investment advice. QUANTSCASE is a stock screener, not a SEBI-registered investment adviser, research analyst, or portfolio manager. Terms
Price & returns
- Last close
- ₹407.25
- 1-day return
- +3.0%
- 1-week return
- +1.4%
- 1-month return
- +0.2%
Technical signals
Latest daily indicators. These are screen readings, not buy or sell calls.
- RSI (14)
- 62.2
- ADX (14)
- 5.7
- ROC 10
- +0.9%
- vs 52W high
- -40.5%
Fundamentals snapshot
Latest fields from our NSE fundamentals table. Figures can lag the live tape.
- Market cap
- ₹16,392 Cr
- P/E
- 74.0
- P/B
- 3.38
- ROE
- —
- D/E
- 9.47
- Net margin
- 6.1%
- Rev. growth YoY
- -27.7%
- Div. yield
- 31.0%
- 52W high
- ₹679
- 52W low
- ₹375.3
- EPS (TTM)
- ₹5.5
Live signals
Built from the latest price, 1-day / 1-week return, and technical snapshot — not a news calendar.
- signal
1-day return +3.0%
Latest 1-day price change versus the previous close.
- signal
1-week return +1.4%
Price change over the last five trading sessions.
News & screener mentions
Recent QUANTSCASE daily posts that listed SYNGENE.
No recent screener posts mentioned SYNGENE yet. New daily posts will show up here automatically.
